Document is current
Any future updates will be listed below
-
Authors
Kohlhase, Konstantin https://orcid.org/0000-0002-1088-9558
Vollmann, Valentin
Bohmann, Ferdinand O.
Grefkes, Christian
Heuser, Antonia
Meci, Klodiana
Göpfert, Jens
Foerch, Christian
-
Funding
Funding for this research was provided by:
Merck Healthcare Germany GmbH (https://doi.org/10.13039/100009945)
Johann Wolfgang Goethe-Universität, Frankfurt am Main
- License Information
-
More Information
Article History
Received: 25 May 2025
Accepted: 28 July 2025
First Online: 20 December 2025
Declarations
:
: The study protocol was approved by the institutional review board of the Goethe-University Frankfurt (IRBnumber 2021-442).
: Informed consent was obtained from all individual participants included in the study.
: Nothing to declare.
: The University hospital Frankfurt received a research grant from Merck Healthcare Germany GmbH, K. Kohlhaseand C. Foerch were responsible for the financial distribution of the research grant. C. Foerch reports speaker honoraria and honoraria for participating in advisory boards from Alexion, AstraZeneca, Abbott, Bristol Myers Squibb, Novartis, Teva, Merck, Sanofi Genzyme and Roche. C. Foerch is inventor of the following patent: Use of GFAP for identification of intracerebral hemorrhage. V. Vollmann, K. Meci, J. Goepfert, C. Grefkes and A. Heuser report no conflicts of interest. F. O. Bohmann reports a relationship with Laerdal, AstraZeneca, Bristol-Myers-Squibb, Pfizer, Medtronic that includes: speaking and lecture fees. Ferdinand O. Bohmann reports a relationship with Alexion, AstraZeneca, Stryker Neurovascular, and Boehringer Ingelheim that includes: funding grants.
